DNA test shows promise for identifying patients with colorectal cancer (p 1283)April 14, 2004Testing for DNA changes in stools might provide a new, accurate, and less invasive way to screen patients for colorectal cancer, conclude the authors of a research letter in this week's issue of THE LANCET. Colorectal cancer is one of the most common cancers in the industrialised world, and early detection might help to reduce the risk of death from the disease. However, although several methods of detection are available, these procedures are either uncomfortable for the patient or are not specific or sensitive enough to be suitable as screening tools. Hannes M Müller from the Medical University Innsbruck, Austria, and colleagues investigated whether patients with colorectal cancer could be identified by testing stool samples for changes in DNA methylation-a form of genetic alteration that is common in colorectal cancer cells. The researchers used a polymerase chain reaction (PCR) assay to identify DNA changes in stools from patients with the disease and from healthy controls, to assess the most promising DNA methylation markers from a long list of candidate genes. They then tested for these potential markers in samples from two sets of patients and healthy controls, comprising a total of 49 individuals. A gene known as SFRP2 was methylated more frequently in DNA from the stools of patients with colorectal cancer than in samples from people without the disease, with a sensitivity of 77-90% and specificity (a measure of reliability, relating to proportion of "false-positive" and "false-negative" results) of 77%. SFRP2 methylation could, therefore, be useful as a marker in screening for colorectal cancer. Martin Widschwendter, the principle investigator of this study, comments: "To our knowledge, SFRP2 methylation represents one of the most sensitive markers for identifying colorectal cancer, besides mutation analysis and protein analysis, in stool samples. Whether a panel of genetic and epigenetic markers in stool could be used to identify colorectal cancer at an early stage remains to be shown." Lancet |
|||||||||||||||||||||
| Related Colorectal Cancer Current Events and Colorectal Cancer News Articles 'Cross-talk' mechanism contributes to colorectal cancer Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have identified a molecular mechanism that allows two powerful signaling pathways to interact and begin a process leading to colorectal tumors. African-Americans with colorectal cancer have poorer outcomes, lower survival rates New research published in the November issue of the Journal of the American College of Surgeons shows that African-American patients with colorectal cancer are more likely to be diagnosed with advanced disease and are less likely to undergo surgical procedures compared with Caucasians, suggesting that improvements in screening and rates of operation may reduce differences in colorectal cancer outcomes for African-Americans. Colon cancer screening more effective earlier in day, UCLA study finds The effectiveness of a screening colonoscopy may depend on the time of day it is performed. According to a new UCLA study, early-morning colonoscopies yielded more polyps per patient than later screenings, and fewer polyps were found hour by hour as the day progressed. 1 disease, not 1 demographic The Asian continent has nearly four billion people living in 47 different countries, and each of these groups has their own unique set of health issues. But when they come to the United States, they're often lumped into one large demographic: "Asian/Pacific Islander." Study shows unsedated colonoscopy for colorectal cancer screening well accepted by patients Researchers from Taiwan report in a new study that unsedated colonoscopy for primary colorectal cancer screening is well accepted in a majority of patients. M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers Drawing on years of experience in cancer research and patient care, The University of Texas M. D. Anderson Cancer Center released today the most comprehensive, risk-based screening guidelines publicly available to date for breast, cervical and colorectal cancers. The bowels of infection Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD). The related report by Onyeagocha et al, "Latent cytomegalovirus infection exacerbates experimental colitis," appears in the November 2009 issue of The American Journal of Pathology. How to Lower Costs, Waiting Times for Colonoscopies Colorectal cancer is a leading cause of cancer-related deaths in the United States, leading to over 50,000 fatalities every year. Excess body weight causes over 124,000 new cancers a year in Europe At least 124,000 new cancers in 2008 in Europe may have been caused by excess body weight, according to estimates from a new modelling study. Adding cetuximab to chemotherapy reduces advanced lung cancer death risk by 13 percent Patients with advanced non-small cell lung cancer who are given cetuximab (Erbitux) in addition to chemotherapy are 13% less likely to die than those who receive chemotherapy alone, regardless of which chemotherapy drug cocktail is used, new research finds. They also experience slower disease progression and an increased chance of tumour shrinkage. More Colorectal Cancer Current Events and Colorectal Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||